Publication & Citation Trends
Publications
0 total
Abstract 1717: KRAS mutant gene editing prevents tumor growth in vivo and overcomes acquired resistance to KRASG12C inhibitor
Cited by 0
Semantic Scholar
Alterations in BRCA2 as Determinants of Therapy Response in Prostate Cancer.
Cited by 1
Semantic Scholar
Abstract 1826: CRISPR mediated KRAS mutant gene editing in pancreatic and colorectal cancer therapy
Cited by 0
Semantic Scholar
Abstract 3948: Simultaneousin vivoPTEN rescue and KRAS silencing in cancer therapy
Cited by 0
Semantic Scholar
Bexarotene and erlotinib for aerodigestive tract cancer.
Cited by 58
Semantic Scholar
Specific Chemopreventive Agents Trigger Proteasomal Degradation of G1 Cyclins: Implications for Combination Therapy
Cited by 64
Semantic Scholar
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers OA
Cited by 101
Semantic Scholar
Electrolyzed Oxidized Water in Treating Mild to Moderate Acne
Cited by 6
Semantic Scholar
Research Topics
Cancer Treatment and Pharmacology
(48)
Nanoparticle-Based Drug Delivery
(19)
Cancer, Hypoxia, and Metabolism
(12)
Multiple Myeloma Research and Treatments
(9)
HER2/EGFR in Cancer Research
(9)
Affiliations
Roche (Switzerland)
Brigham and Women's Hospital
Translational Genomics Research Institute
MedStar Washington Hospital Center
Roswell Park Comprehensive Cancer Center